Published • loading... • Updated
Health Catalyst anticipates $246M-$249M 2026 revenue following Vitalware divestiture (NASDAQ:HCAT)
Health Catalyst said the debt retirement strengthens its balance sheet as it shifts resources to core health system software and analytics.
Summary by Seeking Alpha
4 Articles
4 Articles
MissoulianReposted by 
Montana Standard
Montana StandardHealth Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
Company retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance.
·Missoula, United States
Read Full Article
M&A: Health Catalyst Closes $147M Sale of Vitalware to Med-Metrix
What You Should Know Healthcare intelligence leader Health Catalyst, Inc. completed the sale of its mid-revenue cycle business, Vitalware, LLC, to Med-Metrix, LLC on July 31, 2026.The divestiture generated $147M in total cash consideration, subject to customary adjustments.Health Catalyst combined the net proceeds with cash on hand to fully repay and retire its credit facility, eliminating approximately $19M in annual GAAP interest expense.Capit…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
